How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support

Maurice J. Berkowitz,Carlie K. Thompson,Laura T. Zibecchi,Minna K. Lee,Elani Streja,Jacob S. Berkowitz,Cachet M. Wenziger,Jennifer L. Baker,Maggie L. DiNome,Deanna J. Attai
DOI: https://doi.org/10.1007/s11764-020-00908-5
2020-08-17
Journal of Cancer Survivorship
Abstract:Many patients with hormone receptor–positive (HR+) breast cancer do not adhere to endocrine therapy (ET), and treatment-related side effects are often discussed by participants in online breast cancer forums. Our aim was to survey this unique group of patients about their ET-related experiences.
oncology,social issues
What problem does this paper attempt to address?